1. Using temozolomide as a first new alkalating agent approved for treatment of malignant gliomas describe its mechanism of action, clinical benefits and major site effects. Compare to other compounds with similar mechanism of action. 2. Present the comparison of clinical benefits of the use of antineoplastic drugs. What criteria […]